An Efficient and Versatile Mammalian Viral Vector System for Major Histocompatibility Complex Class I/Peptide Complexes
Open Access
- 1 December 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (23) , 11982-11988
- https://doi.org/10.1128/jvi.76.23.11982-11988.2002
Abstract
We report a Sendai virus (SeV) vector system for expression of major histocompatibility complex (MHC) class I/peptide complexes. We cloned the extracellular domain of a human MHC class I heavy chain, HLA-A*2402, and human β-2 microglobulin (β2m) fused with HLA-A*2402-restricted human immunodeficiency virus type 1 (HIV-1) cytotoxic T-lymphocyte (CTL) epitopes (e-β2m) in separate SeV vectors. When we coinfected nonhuman mammalian cells with the SeVs, naturally folded human MHC class I/peptide complexes were secreted in the culture supernatants. Biotin binding peptide sequences on the C terminus of the heavy chain were used to tetramerize the complexes. These tetramers made in the SeV system recognized specific CD8-positive T cells in peripheral blood mononuclear cells of HIV-1-positive patients with a specificity and sensitivity similar to those of MHC class I tetramers made in anEscherichia colisystem. Solo infection of e-β2m/SeV produced soluble e-β2m in the culture supernatant, and cells pulsed with the soluble protein were recognized by specific CTLs. Furthermore, when cells were infected with e-β2m/SeV, these cells were recognized by the specific CTLs more efficiently than the protein pulse per se. SeV is nonpathogenic for humans, can transduce foreign genes into nondividing cells, and may be useful for immunotherapy to enhance antigen-specific immune responses. Our system can be used not only to detect but also to stimulate antigen-specific cellular immune responses.Keywords
This publication has 47 references indexed in Scilit:
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- Accumulation of Specific Amino Acid Substitutions in HLA-B35-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T Lymphocyte EpitopesAIDS Research and Human Retroviruses, 1999
- Dendritic Cell Vaccines for Cancer ImmunotherapyAnnual Review of Medicine, 1999
- MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSINGAnnual Review of Immunology, 1998
- Sendai virus‐based expression of HIV‐1 gp120: reinforcement by the V(−) versionGenes to Cells, 1997
- Structure of the complex between human T-cell receptor, viral peptide and HLA-A2Nature, 1996
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the CytosolCell, 1996
- Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic.The Journal of Experimental Medicine, 1995
- Use of Peptide Libraries to Map the Substrate Specificity of a Peptide-Modifying Enzyme: A 13 Residue Consensus Peptide Specifies Biotinylation in Escherichia coliNature Biotechnology, 1993